Alpha Laboratories offers the simple to use Quantum Blue® test format to provide the ideal solution for clinicians and point of care applications.
The Quantum Blue reader can be used with a number of different assays to give quantitative results in a time frame that can impact the clinical decision. This includes:
Quantum Blue® fCAL is a rapid, quantitative Calprotectin testing platform for lower throughput requirements.
If your Calprotectin test request number is too low to achieve a reasonable turn around time using an ELISA method, or you require rapid results, Quantum Blue® provides a comprehensive, cost effective, entry-level Calprotectin testing platform. Quantum Blue® can be used in either the clinic or laboratory setting.
New Extended Range Kit
The extended range kit is for use with Quantum Blue Two second generation instruments
(Serial no. >1000)
The Quantum Blue® ascitesCAL (LF-ASC25), is a quantitative test designed for the determination of elevated Calprotectin concentrations in human ascites in combination with the Quantum Blue® Reader.
It is used as an aid to diagnose the development of spontaneous bacterial peritonitis (SBP) by being a marker for an elevated polymorphonuclear cell count (PMN).
The test has been designed for point of care testing of patients suffering from liver cirrhosis accompanied with ascites accumulation in the peritoneum.
Calprotectin is used as a surrogate marker for the elevated presence of polymorphonuclear cells (PMN).
Quantum Blue® sCAL (LF-MRP25) is a quantitative test designed to determine the level of calprotectin in serum and is used as a surrogate marker for the presence of elevated polymorphonuclear cells. The test has been demonstrated to be useful in:
Helping to Manage Juvenile Idiopathic Arthritis
Great Ormond Street Hospital User Report – Serum Calprotectin Monitoring
The BÜHLMANN Quantum Blue® Therapeutic Drug Monitoring assays are the first rapid tests to measure Infliximab and Adalimumab trough level in patient’s serum, allowing timely decision making for dose adjustments before the next dose.